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The cause of trachoma is Chlamydia trachomatis, but its main determinant is poverty. especially low 
water and latrine coverage. The trachoma global control programme strategy is S.A.F.E.: Surgery and 
Antibiotics – medical interventions; Facial cleanliness and Environmental improvement – social 
interventions. Over a ten year period, 2000-2010, the Ghana Trachoma Control Programme has reduced 
the prevalence of trachoma from 9.7-16.1% to less than 2.8% in endemic districts. Through increased 
water coverage from a low 6.67% to a high 96.3%, and latrine coverage from a low 1% to a high 30.8% 
at district level as part of a comprehensive SAFE strategy, Ghana is set to achieve the elimination of 
blinding trachoma, the first sub-Saharan country to do so. The strong collaboration between the health, 
education and WATSAN sectors within the National Trachoma Taskforce has demonstrated how a 
disease of poverty can be successfully eliminated and contributions made to the MDGs. 
 
 
Background 
Trachoma is the leading cause of preventable blindness in the world. In 2003 WHO estimated that 84 
million people were suffering from active trachoma, 7.6 million people are visually impaired or blinded as a 
result of trachoma (WHO 2003).
 
Population-based surveys provided recent information for 42 out of 57 
endemic countries. 40.6 million people are estimated to be suffering from active trachoma, and 8.2 million 
are estimated to have trichiasis (Mariotti et al. 2009). Overall, Africa is the most affected continent: 27.8 
million cases of active trachoma (68.5% of all) and 3.8 million cases of trichiasis (46.6% of all) are located 
in 28 of the 46 countries in the WHO African Region, with an estimated population of 279 million living in 
endemic areas (Mariotti et al 2009). 
Trachoma is a disease of the poorest of the poor and those who are deprived of water and sanitation and is 
thus common in developing countries. Trachoma begins in early childhood and progresses over the years as 
episodes of re-infection cause inflammation and scarring of the conjunctiva. The scarring causes the upper 
eyelid to turn inwards thus causing the eyelashes to rub on the cornea (cicatricial trachoma or trichiasis). 
This in turn results in corneal abrasions, corneal scarring, opacification and ultimately blindness, usually at 
age 40 years and above, although trachoma blindness has also been seen in people much younger (Bowman 
et al 2001). 
The elimination of blinding trachoma would vastly contribute to the improvement of the quality of life, 
provide relief from the suffering from the misery of trichiasis – eyelashes rubbing on the cornea, prevent 
blindness and raise them out of poverty as they return to active work. This will in turn contribute to the 
socio-economic development of their communities. The strategies in tackling trachoma would contribute to 
the overall improvement of health systems and the social determinants of health. 
WHO made a call in 1997 for a Global Elimination of blinding Trachoma by 2020 and endorsed a 
strategy- SAFE. SAFE stands for: 
 
Surgery - To correct in-turned lashes 
Antibiotics - To treat active infection, using Azithromycin 
Facial Cleanliness - To reduce disease transmission through face washing 
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Environmental Improvement - To increase access to clean water and improve sanitation to facilitate 
  disease elimination  
 
WHO has defined elimination of blindness due to trachoma as: 
 
 The prevalence of active trachoma – which is characterized by redness, itching and discharge in the eyes 
as well as the presence of follicles in the conjunctiva of the upper eyelid – is less than 5 percent among 
children aged 1-9 years old and 
 The prevalence of trachoma trichiasis – in-turned eyelashes rubbing on the cornea – is less than 1 case 
per 1,000 population. 
 
Since this call, many stakeholders have heeded the call in providing drugs, funds, clean water, sanitation 
facilities and technical support for implementing the WHO endorsed SAFE strategy for the control of 
trachoma. Also implementing the full SAFE strategy contributes to the achievement of all the Millennium 
Development Goals. Surgery prevents blindness and contributes to poverty reduction (MDG1). Children are 
healthier and can attend school regularly (MDG2) Provision of sanitation facilities in schools promotes girl 
attendance (MDG2) Provision of safe water reduce incidence of diarrhoeal diseases thereby contributing to 
infant and child mortality (MDG4, 5, 6) Improved environment (MDG7) Improved partnerships (MDG8) 
 
Ghana 
“Ghana Free of Blinding Trachoma” is the vision of the Ghana Trachoma Control Programme which has its 
goal of eliminating blinding trachoma from Ghana by 2010. Baseline epidemiological surveys conducted in 
the two endemic regions (Northern and Upper West Regions) in Ghana showed that the prevalence of active 
trachoma ranged from 2.8 to 16.1% among children aged 1-9 years old and the prevalence of trachoma 
trichiasis ranged from 0.4 to 8.4% among adults above 40 years at the district level. About 2.8 million 
people are at risk of the disease and an estimated 13,000 people had trichiasis (the potentially blinding stage 
of the disease) at the inception of the programme. The Ghana Health Service together with all partners has 
been working in a concerted effort to get Ghana free of trachoma blindness. The programme started in the 
year 2000 after baseline survey results showed that there was trachoma of public health significance in the 
Northern and Upper West Regions. Control activities using the WHO endorsed SAFE strategy, including the 
provision of safe water and latrines, were implemented in all the endemic districts. An Impact Assessment 
Survey and a Mid-Term Review carried out in 2007/2008 indicated that the prevalence rates of active 
trachoma had reduced to between 0.14% and 2.80% at the district level. 
 
Key activities, key achievements and partners of the programme 
 
Implementing S&A - the medical interventions for trachoma 
The Ghana Trachoma Control Programme has been implementing the full SAFE strategy over the past 10 
years. The overall coordinator for the programme is the Ghana Health Service/Ministry of Health. Surgery 
to correct the in-turned eye lashes of affected individuals was conducted. So far over 5,000 people have 
benefitted from this lid surgery. The partners which support trichiasis surgery include the International 
Trachoma Initiative (ITI), Sightsavers, Operation Eye Sight Universal and the Swiss Red Cross. Pfizer, a 
pharmaceutical company in the USA donated the antibiotic Zithromax® through the I.T.I. to be used to treat 
members of endemic communities. Over 3.3 million doses of this drug have been given to treat about 1 
million people for at least three consecutive years. Hygiene promotion through electronic and print media as 
well as direct household and community sessions were conducted in all the endemic districts. School health 
education activities were also conducted in all the 29 endemic districts by the Ghana Education Service 
through its School Health Education Programme. 
 
Implementing F&E - the social and development interventions for the trachoma 
Water and household latrines were provided by both the Government of Ghana and other partners. Our key 
partners in the Water and Sanitation sector include the Community Water and Sanitation Agency (CWSA) 
Environmental Health Divisions of the District Assemblies and the Ministry of Local Government, Rural 
Development and Environment. International NGOs such as World Vision Ghana, WaterAid Ghana and 
The Carter Center provided water and household latrines to endemic communities. UNICEF also provided 
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safe water and latrines to schools in the endemic districts. Together over the last 10 years, these partners 
provided a total of 5,354 safe water points such as small town systems, boreholes and hand dug wells; and 
more than 12,000 household latrines. 
 
Impact 
The water coverage improved from 50% to 80% and latrine coverage improved from as low as 1% to 38% 
in the programme areas. The backlog of people with trichiasis reduced from 13,000 to less than 5,000. The 
impact of all this was a reduction in the prevalence of active trachoma from 16.1% to as low as 2.8% – well 
below the WHO accepted prevalence of 5%. The percentage of children with clean faces – faces without 
discharge – rose from 70% to 93% in the endemic areas. 
 
 
Prevalence of Active Trachoma in Districts in the Two Endemic Regions- Northern and 
Upper West Regions of Ghana 
Bar Chart Comparing Baseline and Follow-up Prevalence Rates
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Diagram 1. Baseline prevalence rates compared with the impact assessment prevalence results 
per district in the Northern and Upper West Regions 
 
 
Discussion 
The benefits of the provision of water and sanitation facilities as part of the efforts in implementing the full 
SAFE strategy in trachoma endemic communities cannot be overemphasized. The programme in Ghana 
proves this point where the prevalence of trachoma has been greatly reduced from as high as 16% to a low 
of 2.8% for active trachoma. Similar results have been seen in a country such as Morocco, where 
implementing the full SAFE strategy led to a reduction of blinding trachoma to a level that it is no longer of 
Public Health significance (Kumaresan & Mecaskey 2003; Ministry of Health Morocco 2006). The 
provision of water and sanitation as part of development led to the elimination of blinding trachoma in parts 
of Europe. During the 19th and early 20th centuries, trachoma was widespread
 
in Europe and North America 
and was a leading exclusion criterion
 
for European immigrants coming through Ellis Island into the
 
United 
States (Markel 2000). Due in large part to improvements in hygiene
 
and sanitation, trachoma is no longer 
endemic in these areas.
 Rather it persists in the world‟s poorest, under privileged and least served 
communities (Allen & Semba 2002). Women and men who have had surgery have been able to get back to 
economic activities to support their homes. This helps in reducing poverty. Women are able to use their time 
for other gains when access to clean water is easier. This helps to reduce poverty and improves lives of 
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individuals and whole communities. Based on the risk factors of dry dusty environment, lack of water and 
lack of proper disposal of excreta, for trachoma, there is an assumption that where there are no water and 
sanitation facilities, communities which had earlier on been seemingly free from trachoma may see the 
disease bouncing back. This has not however been proven. Access to and use of safe water and sanitation 
could help to maintain the gains made through the use of antibiotics in treating active disease. Thus the role 
of our partners in the WATSAN sector in the programme to eliminate blindness due to trachoma and 
maintain gains made is very crucial. 
 
Conclusion 
The implementation of the full SAFE strategy for the control of trachoma by a strong partnership of both 
medical and socio-development agencies and organizations working together towards a common goal, 
placing equal importance on the provision of water and sanitation facilities and the medical interventions 
of surgery and treatment with antibiotics has brought Ghana close to the elimination of blindness due to 
trachoma. 
 
The authors would like to extend thanks to the Ghana National Trachoma Task Force members, Ghana 
Health Service/Ministry of Health and all partners of the Ghana Trachoma Control Programme including the 
districts and community members of the endemic communities. 
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